Evaluation of the Nextdoor KIND Challenge

计划入组 4,500 人 · 首次发布于 2020 年 5 月 21 日

Effectiveness of Pharmacotherapy Follow-up Care in Outpatients With Type 2 Diabetes Mellitus

计划入组 60 人 · 首次发布于 2017 年 6 月 22 日

Placebo Controlled Study of Sublingual Salvinorin A

计划入组 8 人 · 首次发布于 2010 年 6 月 24 日

monoclonal antibody-drug conjugate

KIND-101D

anivovetmab

Kind Pharmaceuticals LLC

United States

Eton Pharmaceutical

United States

Ultragenyx Pharmaceutical

Chile

FDA Grants Orphan Drug Designation to Kind Pharmaceutical's AND017 for Sickle Cell Disease

AND017 Receives FDA Orphan Drug Designation for Sickle Cell Disease

AND017 Shows Promise in Treating Anemia Associated with Chronic Kidney Disease